National Research Corp.

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: US6373722023
USD
16.32
0.12 (0.74%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About National Research Corp. stock-summary
stock-summary
National Research Corp.
Miscellaneous
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect. The Company's portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions and physician engagement. NRC Health partners with clients across the range of healthcare services. The Company's clients range from integrated health systems and post-acute providers, such as home health, long-term care and hospice, to payer organizations. NRC Health's portfolio of solutions is designed to help healthcare companies.
Company Coordinates stock-summary
Company Details
1245 Q St , LINCOLN NE : 68508-1430
stock-summary
Tel: 1 402 47525251 402 4752525
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 40 Schemes (26.02%)

Foreign Institutions

Held by 72 Foreign Institutions (8.53%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Michael Hays
President, Chief Executive Officer, Director
Mr. John Nunnelly
Lead Independent Director
Dr. Donald Berwick
Independent Director
Ms. JoAnn Martin
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
34 Million
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 448 Million (Micro Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.57%

stock-summary
Debt Equity

3.55

stock-summary
Return on Equity

84.49%

stock-summary
Price to Book

21.03